{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:16:27Z","timestamp":1791303387938,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jaad.2012.09.051","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T04:46:39Z","timestamp":1354941999000},"page":"S28-S38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"S1","title":["Current issues in the management of actinic keratosis"],"prefix":"10.1016","volume":"68","author":[{"given":"Roger I.","family":"Ceilley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Jorizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2012.09.051_bib1","unstructured":"Society for Investigative Dermatology, American Academy of Dermatology Association. The burden of skin diseases, 2005. Available from: URL:http:\/\/www.lewin.com\/\u223c\/media\/lewin\/site_sections\/publications\/april2005skindisease. Accessed April 26, 2012."},{"key":"10.1016\/j.jaad.2012.09.051_bib2","first-page":"1045","article-title":"Frequency and cost of actinic keratosis treatment","volume":"32","author":"Warino","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2012.09.051_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1524-4725.1995.tb00141.x","article-title":"Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant?","volume":"21","author":"Hurwitz","year":"1995","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2012.09.051_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-4362.1998.00467.x","article-title":"Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma","volume":"37","author":"Mittelbronn","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/120347540200600301","article-title":"The majority of cutaneous squamous cell carcinomas arise in actinic keratoses","volume":"6","author":"Czarnecki","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2012.09.051_bib6","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs topical tretinoin chemoprevention trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2012.09.051_bib7","first-page":"3604","article-title":"p53 Mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization","volume":"55","author":"Kanjilal","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2012.09.051_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2008.01.042","article-title":"Genomic instability, mutations and expression analysis of the tumor suppressor genes p14ARF, p15INK4b, p16INK4a and p53 in actinic keratosis","volume":"264","author":"Kanellou","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jaad.2012.09.051_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archdermatol.2009.378","article-title":"Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression","volume":"146","author":"Padilla","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib10","first-page":"39","article-title":"Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer","volume":"3","author":"Cohen","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib11","first-page":"1","article-title":"Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel","volume":"55","author":"Berman","year":"2006","journal-title":"J Fam Pract"},{"key":"10.1016\/j.jaad.2012.09.051_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archderm.1995.01690140054008","article-title":"High sun protection factor sunscreens in the suppression of actinic neoplasia","volume":"131","author":"Naylor","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib13","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJM199310143291602","article-title":"Reduction of solar keratoses by regular sunscreen use","volume":"329","author":"Thompson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.09.051_bib14","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1158\/1055-9965.EPI-06-0352","article-title":"Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use","volume":"15","author":"van der Pols","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2012.09.051_bib15","first-page":"169","article-title":"Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach","volume":"84","author":"Lee","year":"2009","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2012.09.051_bib16","first-page":"667","article-title":"Treatment options for actinic keratoses","volume":"76","author":"McIntyre","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2012.09.051_bib17","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2133.2008.08488.x","article-title":"Multicenter intraindividual randomized trial of topical methyl aminolevulinate-photodynamic therapy vs cryotherapy for multiple actinic keratoses on the extremities","volume":"158","author":"Kaufmann","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-4632.2004.02056.x","article-title":"A prospective study of the use of cryosurgery for the treatment of actinic keratoses","volume":"43","author":"Thai","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00128071-200001030-00004","article-title":"Actinic keratosis: current treatment options","volume":"1","author":"Jeffes","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib20","first-page":"1727","article-title":"A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications","volume":"63","author":"Braakhuis","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2012.09.051_bib21","doi-asserted-by":"crossref","first-page":"14025","DOI":"10.1073\/pnas.93.24.14025","article-title":"Frequent clones of p53-mutated keratinocytes in normal human skin","volume":"93","author":"Jonason","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2012.09.051_bib22","first-page":"32","article-title":"Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing","volume":"3","author":"Rendon","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib23","first-page":"9","article-title":"Treatment options in the management of actinic keratosis","volume":"74","author":"Jorizzo","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2012.09.051_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1524-4725.1999.99035.x","article-title":"Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers","volume":"25","author":"Fulton","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2012.09.051_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/157488706775246166","article-title":"Topical therapy for actinic keratoses: current and evolving therapies","volume":"1","author":"Weinberg","year":"2006","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.jaad.2012.09.051_bib26","series-title":"Carac cream, 0.5% [package insert]","year":"2009"},{"key":"10.1016\/j.jaad.2012.09.051_bib27","series-title":"Solaraze gel, diclofenac sodium, 3% [package insert]","year":"2011"},{"key":"10.1016\/j.jaad.2012.09.051_bib28","series-title":"Zyclara (imiquimod) cream, 3.75% [package insert]","year":"2011"},{"key":"10.1016\/j.jaad.2012.09.051_bib29","series-title":"Aldara (imiquimod) cream, 5% [package insert]","year":"2010"},{"key":"10.1016\/j.jaad.2012.09.051_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2003.12.010","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials","volume":"50","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib31","first-page":"144","article-title":"Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp","volume":"6","author":"Tanghetti","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2009.07.004","article-title":"Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles","volume":"62","author":"Swanson","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/TCRM.S1769","article-title":"Review of photodynamic therapy in actinic keratosis and basal cell carcinoma","volume":"4","author":"Ericson","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jaad.2012.09.051_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1751-1097.2007.00276.x","article-title":"Photodynamic therapy in the treatment of actinic keratosis","volume":"84","author":"Stritt","year":"2008","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.jaad.2012.09.051_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1468-3083.2011.04386.x","article-title":"Daylight photodynamic therapy for actinic keratosis: an international consensus; International Society for Photodynamic Therapy in Dermatology","volume":"26","author":"Wiegell","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2012.09.051_bib36","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2133.2008.08450.x","article-title":"Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study","volume":"158","author":"Wiegell","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2011.10209.x","article-title":"A randomized, multicenter study of directed daylight exposure times of 1(1\/2) vs 2(1\/2) h in daylight-mediated photodynamic therapy with methyl aminolevulinate in patients with multiple thin actinic keratoses of the face and scalp","volume":"164","author":"Wiegell","year":"2011","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2012.09.051_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2133.2007.08271.x","article-title":"A randomized study of topical 5% imiquimod vs topical 5-fluorouracil vs cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up","volume":"157","author":"Krawtchenko","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1085-5629(03)00040-3","article-title":"Topical and light-based treatments for actinic keratoses","volume":"22","author":"Silapunt","year":"2003","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2012.09.051_bib40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archderm.140.7.813","article-title":"Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial","volume":"140","author":"Jorizzo","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1524-4725.1983.tb00824.x","article-title":"Combination of topical 5-fluorouracil with cryotherapy for treatment of actinic keratoses","volume":"9","author":"Abadir","year":"1983","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.jaad.2012.09.051_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2230.2008.02783.x","article-title":"Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses","volume":"34","author":"Mastrolonardo","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/14764170903480005","article-title":"Case-based experience in the use of 5-fluorouracil cream 0.5% as monotherapy and in conjunction with glycolic acid peels for the treatment of actinic keratosis","volume":"12","author":"Goldberg","year":"2010","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.jaad.2012.09.051_bib44","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1524-4725.1998.tb04290.x","article-title":"The new fluor-hydroxy pulse peel: a combination of 5-fluorouracil and glycolic acid","volume":"24","author":"Marrero","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2012.09.051_bib45","first-page":"174","article-title":"Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid\u2013pilot study","volume":"8","author":"Schlaak","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2012.09.051_bib46","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jaad.2011.11.933","article-title":"A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes","volume":"66","author":"Serra-Guill\u00e9n","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib47","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archderm.140.4.408","article-title":"Objective assessment of compliance with psoriasis treatment","volume":"140","author":"Zaghloul","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib48","first-page":"651","article-title":"Development of a treatment algorithm for actinic keratoses: a European consensus","volume":"18","author":"Stockfleth","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib49","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0149-2918(02)80012-1","article-title":"Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis","volume":"24","author":"Loven","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2012.09.051_bib50","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2002.126257","article-title":"Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open-label trial","volume":"47","author":"Salasche","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib51","unstructured":"Carter S, Taylor D. A question of choice\u2013compliance in medicine taking, a preliminary review. Medicine Partnership October 2003. Available from: URL:http:\/\/www.keele.ac.uk\/pharmacy\/npcplus\/medicinespartnershipprogramme\/medicinespartnershipprogrammepublications\/aquestionofchoicecomplianceinmedicinetakin\/research-qoc-compliance.pdf. Accessed April 26, 2012."},{"key":"10.1016\/j.jaad.2012.09.051_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/09546630600688515","article-title":"Adherence in dermatology: a review of the last 20 years","volume":"17","author":"Hodari","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2012.09.051_bib53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2340\/00015555-0073","article-title":"To follow or not to follow dermatological treatment\u2013a review of the literature","volume":"86","author":"Serup","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2012.09.051_bib54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/09546630902991476","article-title":"Literature is lacking in discussion of non-adherence in dermatology","volume":"21","author":"Baer","year":"2010","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2012.09.051_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00128071-200607040-00004","article-title":"Pharmionics in dermatology: a review of topical medication adherence","volume":"7","author":"Lee","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib56","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaad.2004.01.052","article-title":"Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use","volume":"51","author":"Carroll","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archdermatol.2008.562","article-title":"Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses","volume":"145","author":"Yentzer","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2008.03.045","article-title":"One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic","volume":"59","author":"Storm","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0846.2010.00431.x","article-title":"Assessing adherence to dermatology treatments: a review of self-report and electronic measures","volume":"16","author":"Greenlaw","year":"2010","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.jaad.2012.09.051_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaad.2007.04.005","article-title":"Adherence to topical therapy increases around the time of office visits","volume":"57","author":"Feldman","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jaad.2009.02.022","article-title":"Quality of life in the actinic neoplasia syndrome: the VA topical tretinoin chemoprevention (VATTC) trial","volume":"61","author":"Weinstock","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1468-3083.2011.04005.x","article-title":"Open label randomized study comparing 3 months vs 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German dermatologic cooperative oncology group","volume":"26","author":"Pflugfelder","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2012.09.051_bib63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2006.07692.x","article-title":"Guidelines for the management of actinic keratoses","volume":"156","author":"de Berker","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib64","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1524-4725.2010.01675.x","article-title":"Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms","volume":"36","author":"Terushkin","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2012.09.051_bib65","series-title":"Metvixia cream","year":"2008"},{"key":"10.1016\/j.jaad.2012.09.051_bib66","series-title":"Levulan Kerastick","year":"2010"},{"key":"10.1016\/j.jaad.2012.09.051_bib67","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1517\/14728214.2010.507191","article-title":"Emerging drugs for actinic keratosis","volume":"15","author":"Ulrich","year":"2010","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jaad.2012.09.051_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00128071-200102010-00002","article-title":"Electronic monitoring in medication adherence measurement: implications for dermatology","volume":"2","author":"Koehler","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib69","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-2133.2009.09260.x","article-title":"Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial","volume":"161","author":"Gebauer","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib70","first-page":"1281","article-title":"Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine","volume":"9","author":"Alberts","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2012.09.051_bib71","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(00)04214-8","article-title":"Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomized study; xeroderma pigmentosum study group","volume":"357","author":"Yarosh","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2012.09.051_bib72","first-page":"1519","article-title":"Reduced number of actinic keratoses with topical application of DNA repair enzyme creams","volume":"9","author":"DeBoyes","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib73","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2133.2008.08615.x","article-title":"A phase II dose-ranging study of topical resiquimod to treat actinic keratosis","volume":"159","author":"Szeimies","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib74","first-page":"128","article-title":"Treatment of actinic keratoses with a novel betulin-based oleogel: a prospective, randomized, comparative pilot study","volume":"7","author":"Huyke","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2012.09.051_bib75","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.09.051_bib76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2133.2009.09253.x","article-title":"Adherence to topical dermatological therapy: lessons from oral drug treatment","volume":"161","author":"Gupta","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib77","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2008.07.039","article-title":"A prospective study of patient adherence to topical treatments: 95% of patients underdose","volume":"59","author":"Storm","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib78","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1365-2133.2007.07754.x","article-title":"Single application of a fluorescent test cream by healthy volunteers: assessment of treated and neglected body sites","volume":"156","author":"Ulff","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib79","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1365-2133.2011.10480.x","article-title":"Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis","volume":"165","author":"Pouplard","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib80","first-page":"24","article-title":"Patient education strategies in dermatology, part 1: benefits and challenges","volume":"2","author":"Zirwas","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib81","first-page":"28","article-title":"Patient education strategies in dermatology, part 2: methods","volume":"2","author":"Zirwas","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2340\/00015555-1022","article-title":"Patient education in chronic skin diseases: a systematic review","volume":"91","author":"de Bes","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2012.09.051_bib83","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.disamonth.2008.08.002","article-title":"Nurse practitioners and physician assistants in primary care","volume":"54","author":"Atwater","year":"2008","journal-title":"Dis Mon"},{"key":"10.1016\/j.jaad.2012.09.051_bib84","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaad.2008.06.037","article-title":"The US dermatology workforce: a specialty remains in shortage","volume":"59","author":"Kimball","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaad.2007.09.032","article-title":"Who else is providing care in dermatology practices? Trends in the use of nonphysician clinicians","volume":"58","author":"Resneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2006.04.001","article-title":"Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists","volume":"55","author":"Tsang","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.09.051_bib87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0733-8635(05)70175-3","article-title":"The emerging role of physician assistants in the delivery of dermatologic health care","volume":"18","author":"Clark","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2012.09.051_bib88","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2340\/00015555-0065","article-title":"The role of\u00a0dermatologists, nurses and pharmacists in chronic dermatological treatment: patient and provider views and experiences","volume":"86","author":"Lindblad","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2012.09.051_bib89","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2010.10119.x","article-title":"Patients' views of nurse prescribing: effects on care, concordance and medicine taking","volume":"164","author":"Courtenay","year":"2011","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212010626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212010626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:24:50Z","timestamp":1759271090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962212010626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0190962212010626"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2012.09.051","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718076607.793482231","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current issues in the management of actinic keratosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2012.09.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}